• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Cyclacel Pharmaceuticals, Inc. (CYCC)

    -NasdaqGM
    0.78 Down 0.01(0.65%) Jul 2, 3:59PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 1,734   1,084   69  
    Cost of Revenue -   -   -  
    Gross Profit 1,734   1,084   69  
    Operating Expenses
    Research Development18,277  11,277  6,592  
    Selling General and Administrative5,894  7,781  8,580  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (22,437) (17,974) (15,103)
    Income from Continuing Operations
    Total Other Income/Expenses Net(212)6,094  (4)
    Earnings Before Interest And Taxes(22,649)(11,880)(15,107)
    Interest Expense -   -   -  
    Income Before Tax(22,649)(11,880)(15,107)
    Income Tax Expense(3,243)(1,670)(1,351)
    Minority Interest -   -   -  
    Net Income From Continuing Ops(19,406)(10,210)(13,756)
    Non-recurring Events
    Discontinued Operations19  57  570  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (19,387) (10,153) (13,186)
    Preferred Stock And Other Adjustments(200)(9,325)(728)
    Net Income Applicable To Common Shares (19,587) (19,478) (13,914)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.